ZA723999B - Pharmaceutical powder composition suitable for inhalation - Google Patents

Pharmaceutical powder composition suitable for inhalation

Info

Publication number
ZA723999B
ZA723999B ZA723999A ZA723999A ZA723999B ZA 723999 B ZA723999 B ZA 723999B ZA 723999 A ZA723999 A ZA 723999A ZA 723999 A ZA723999 A ZA 723999A ZA 723999 B ZA723999 B ZA 723999B
Authority
ZA
South Africa
Prior art keywords
inhalation
powder composition
composition suitable
pharmaceutical powder
pharmaceutical
Prior art date
Application number
ZA723999A
Other languages
English (en)
Inventor
S Gunning
P Hartley
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of ZA723999B publication Critical patent/ZA723999B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA723999A 1971-06-22 1972-06-12 Pharmaceutical powder composition suitable for inhalation ZA723999B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2920771A GB1381872A (en) 1971-06-22 1971-06-22 Pharmaceutical compositions for inhalation

Publications (1)

Publication Number Publication Date
ZA723999B true ZA723999B (en) 1973-06-27

Family

ID=10287853

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA723999A ZA723999B (en) 1971-06-22 1972-06-12 Pharmaceutical powder composition suitable for inhalation

Country Status (9)

Country Link
JP (1) JPS5046820A (da)
AU (1) AU462722B2 (da)
CA (1) CA970685A (da)
DE (1) DE2229981C3 (da)
DK (1) DK134970B (da)
FR (1) FR2143163B2 (da)
GB (1) GB1381872A (da)
NL (1) NL176743C (da)
ZA (1) ZA723999B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2332663C2 (de) * 1973-06-23 1986-07-31 Schering AG, 1000 Berlin und 4709 Bergkamen Verwendung von Kortikoid-Wirkstoffen zur Inhalationstherapie
GB1520247A (en) * 1974-08-10 1978-08-02 Fisons Ltd Pelletised medicament formulations
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
EP0266443B1 (en) * 1986-11-03 1993-06-23 Allen W. Jacobs Process for the inclusion of a solid particulate component into aerosol formulations of inhalable nicotine
BE891013A (fr) * 1980-11-05 1982-05-05 Fisons Ltd Compositions pharmaceutique
IT1220979B (it) * 1981-06-04 1990-06-21 Lofarma Farma Lab Capsule contenenti un allergene e procedimento per la loro preparazione
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (de) 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9515182D0 (en) 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
ITMI991582A1 (it) 1999-07-16 2001-01-16 Chiesi Farma Spa Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
EP1238661A1 (en) * 1999-10-12 2002-09-11 Kaken Pharmaceutical Co., Ltd. Powdery inhalational preparations and process for producing the same
GB0009469D0 (en) 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
US7744855B2 (en) 2000-06-27 2010-06-29 Vectura Limited Method of making particles for use in a pharmaceutical composition
EP2298279B1 (en) 2000-11-30 2018-11-14 Vectura Limited Pharmaceutical compositions for inhalation
ES2334642T5 (es) 2000-11-30 2016-03-07 Vectura Limited Partículas para usar en una composición farmacéutica
AR046225A1 (es) 2003-11-04 2005-11-30 Glaxo Group Ltd Compuesto de 8-azoniabiciclo(3.2.1)octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos que lo comprende y uso del compuesto para preparar dicha composicion
MY144753A (en) 2004-04-27 2011-10-31 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
CN104177448A (zh) 2005-02-10 2014-12-03 葛兰素集团有限公司 使用预分选技术制备乳糖的方法以及由此形成的药物制剂
EP3578169A1 (en) 2009-02-26 2019-12-11 Glaxo Group Limited Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
GB201305825D0 (en) 2013-03-28 2013-05-15 Vectura Ltd New use
ES2953293T3 (es) 2018-08-07 2023-11-10 Norton Waterford Ltd Aplicación de espectroscopia Raman para la fabricación de polvos para inhalación

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1122284A (en) * 1965-03-19 1968-08-07 Fisons Pharmaceuticals Ltd Inhalation device
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
JPS5046820A (da) 1975-04-25
DE2229981A1 (de) 1972-12-28
FR2143163B2 (da) 1975-10-31
DK134970B (da) 1977-02-21
GB1381872A (en) 1975-01-29
CA970685A (en) 1975-07-08
NL176743C (nl) 1985-06-03
AU462722B2 (en) 1975-07-03
NL7208207A (da) 1972-12-28
FR2143163A2 (da) 1973-02-02
DK134970C (da) 1977-07-18
NL176743B (nl) 1985-01-02
AU4380572A (en) 1974-01-03
DE2229981C3 (de) 1981-04-02
DE2229981B2 (de) 1980-07-03

Similar Documents

Publication Publication Date Title
ZA723999B (en) Pharmaceutical powder composition suitable for inhalation
ZA73284B (en) Pharmaceutical powder composition containing sodium cromoglycate
CA999202A (fr) Inhalateur de compositions medicamenteuses en poudre avec chambre de tourbillonnement
IL38687A (en) Omega-imidazolyl-omega-phenoxy-alkanones,their preparation and pharmaceutical compositions containing them
CS185569B2 (en) Inhalator for powdered materials
CS187429B2 (en) Inhalator for administering the powder medicines
IL40475A0 (en) Novel tetrazole derivatives,their preparation and pharmaceutical compositions containing them
IE35991L (en) Camphor-containing pharmaceutical composition
IL40184A0 (en) 5-cinnamoyl-benzofurans,their preparation and pharmaceutical compositions containing them
MY7700080A (en) Pharmaceutical compositions
IL40412A0 (en) Substituted 3-hydroxymethyl-isoquinolines and salts thereof,their preparation and pharmaceutical compositions containing them
IL40572A0 (en) Biphenylyl-butanols,their preparation and pharmaceutical compositions containing them
IL48790A0 (en) Novel hydroxy-pyrimidines,their preparation and pharmaceutical compositions containing them
GB1370904A (en) Pharmaceutical composition
IL41200A0 (en) Substituted 3-amino-prop-1-enes,their preparation and pharmaceutical compositions containing them
IL40828A0 (en) Dibenzothiepin derivatives,their manufacture and pharmaceutical compositions containing them
IL40362A0 (en) Novel 4-oxo-4h-1-benzopyran and-thiabenzopyran derivatives,their preparation and pharmaceutical compositions containing them
IL39620A0 (en) Substituted phenylimidazolidinones and their salts,their preparation and pharmaceutical compositions containing them
IL39381A0 (en) Rheadan-type alkaloids,their preparation and pharmaceutical compositions containing them
IL40623A0 (en) New eburnamine-type alkaloids and salts thereof,their preparation and pharmaceutical compositions containing them
IL39355A0 (en) Androstan-17beta-yl-acrylonitrile derivatives,their preparation and pharmaceutical compositions containing them
IL39337A0 (en) Isoindoline derivatives,processes for their preparation and pharmaceutical compositions containing the same
IL40194A0 (en) New phenothiazine derivatives,processes for their preparation and pharmaceutical compositions containing the same
ZA721363B (en) Pharmaceutical composition
IL38772A0 (en) Amino-anthracene derivatives,their manufacture and pharmaceutical compositions containing them